KCT0007103尚未招募未知
Effect of motilitone on gastrointestinal symptoms and continuous glucose measurement in patients with type 2 diabetes with functional dyspepsia.
Kyung Hee University Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18?(Year) 至 o Limit(—)
- 性别
- All
入选标准
- •1) Adults 18 years of age or older
- •2) Those with type 2 diabetes who are being controlled with oral medications (biguanide, sulfonylurea, alpha-glucosidase inhibitor, thiazolidinedione, meglitinide, metformin combination, DPP-4 inhibitor)
- •3) Those who have not changed their diabetes medication in the last 3 months, HbA1c < 9% or less, and have a change within ±0.5 from HbA1C before 3 months
- •4) Those diagnosed with postprandial distress syndrome of functional dyspepsia according to Rome IV diagnostic criteria (in case of postprandial bloating or early feeling of fullness more than 3 days a week, beginning 6 months ago and lasting for 3 months or more )
- •5) Those who have agreed to participate in this exam
排除标准
- •1) Those who are being treated with insulin preparations or GLP1 receptor agonists for the treatment of diabetes
- •2) In case of diabetic renal dysfunction or diabetic retinopathy
- •3) Those who have confirmed organic digestive diseases (eg gastric ulcer, duodenal ulcer, esophageal cancer, gastric cancer, enteritis, colitis, etc.)
- •4) If you have had gastrectomy or vagus nerve resection in the past, and if other lesions that can cause gastrointestinal symptoms are found
- •5) If you are taking drugs that may affect the exercise evaluation of the digestive system
- •6) In case of impaired liver function (AST, ALT 2.5 times the upper limit of normal)
- •7) Persons with serious active medical conditions that may affect quality of life measures (thyroid disease, wasting or infectious disease, active cancer disease, acute respiratory disease, chronic active rheumatism and autoimmune disease, heart failure (NYHA II - IV) Or myocardial infarction, those with cardiovascular stents, etc.)
- •8) Pregnant, lactating, and women of childbearing age who do not use appropriate contraceptive methods
- •9) Others, those who are judged inappropriate by the principal investigator or the person in charge
研究者
相似试验
已完成
不适用
The effect of Motilitone to Gastric Emptying time in patients with DIstal GastrectomyKCT0004084Chung-Ang Univerisity Hospital30
招募中
2 期
comparison of the melatonin effect in irritable bowel syndrome patientsIrritable bowel syndromeIRCT20220104053626N2Tabriz University of Medical Sciences136
招募中
不适用
The effect of serotonergic modulation on intestinal permeability and visceral perception in healthy individuals and IBS patientsfunctional gastrointestinal disorder10017977irritable bowel syndromeNL-OMON33644niversiteit Maastricht60
已完成
不适用
Effect of miglitol and vildagliptin on gastrointestinal hormoneSubjects without diabetesJPRN-UMIN000010481Yokohama City University20
尚未招募
不适用
Effects of motilitone on the improvement of dyspeptic symptoms in patients with depression and anxiety disorder comorbid with dyspepsiaMental and behavioral disordersKCT0004973Wonkwang University Hospital50
